Is chemoprophylaxis a good strategy for tuberculosis control?;¿Es la quimioprofilaxis una buena estrategia para el control de la tuberculosis?

Medicina Clinica

Volumn 116, Issue 6, 2001, Pages 223-229

  Caminero Luna, J A ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Chemoprophylaxis; Control; Epidemiology; Latent tuberculosis infection; Prevention; Preventive treatment; Prophylaxis; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; PROPHYLAXIS; TREATMENT INDICATION; TUBERCULOSIS;

EID: 0035901037     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71777-0     Document Type: Article

References (74)

1. The time-table of tuberculosis
2. Controlled chemoprophylaxis trials in tuberculosis. A general review
3. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
4. A controlled trial of community-wide isoniazid prophylaxis in Alaska
5. Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis five years of follow-up in the IUAT trial
6. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus
7. Tuberculosis elimination revisited: Obstacles, opportunities, and renewed commitment
8. Tuberculosis elimination in the countries of Europe and other industrialized countries
9. Control and prevention of tuberculosis in UK
10. En busca de la oportunidad perdida: Prioridades en el control de la tuberculosis
11. Control and prevention of tuberculosis in the United Kingdom: Code of practice 1994
12. Preventive therapy of tuberculosis infection
13. Quimioprofilaxis antituberculosa. Recomendaciones SEPAR
14. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
15. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia
16. A controlled trial of isoniazid in persons with anergy and human immuno-deficiency virus infection who are at risk for tuberculosis
17. Rifampin and pyrazinamide vs. isoniazid for prevention of tuberculosis in HIV-1 infected persons: An international randomized trial
18. An international, randomized trial of rifampin and pyrazinamide versus isoniazid for prevention of tuberculosis in HIV-1 infected persons
19. Isoniazid preventive for tuberculosis in HIV-1 infected adults: Results of a randomized controlled trial
20. Epidemiology of tuberculosis in the United States
21. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts
22. How much isoniazid is needed for prophylaxis?
23. Isoniazid prophylaxis among Alaskan Eskimos: A final report of the Bethel Isoniazid Studies
24. Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration cooperative study XII
25. Risk of tuberculosis among persons with not active - Not treated, lesions
26. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong
27. Short course chemoprophylaxis with rifampin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners wilh chronic silicosis: A double-blind placebo controlled trial
28. Silicosis in northern Rhodesia coppers miners
29. Silicosis and risk lung cancer or lung tuberculosis: A cohort study
30. The epidemiology of tuberculosis in gold miners with silicosis
31. Varairion in incidence or tuberculosis in subgroups of South African gols miners
32. Role of adrenal cortex in native resistance
33. The effect of hormonal preparations on the survival of mice injected intravenously with virulent, attenuated, and avirulent mycobacteria
34. A critical evaluation of corticosteroids in tuberculosis
35. Tuberculosis emerging in patients treated with corticosteroids
36. The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population
37. Incidence of serious complications ot corticosteroid therapy in respiratory disease. A retrospective survey of patients at Brompton Hospital
38. Is a purified derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids?
39. Tuberculosis among diabetics. The Philadelphia survey
40. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county (I). Incidence of diabetes mellitus in a Swedish county. Survey of diabetics in the county of Kristianstad
41. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county (II). Incidence of pulmonary tuberculosis among diabetics. Search among diabetics in the county of Kristianstad
42. Pulmonary tuberculosis in mitral stenosis and diabetes mellitus
43. PPD y quimioprofilaxis en la diabetes mellitus
44. Drug dependence, a possible new risk factor for tuberculosis disease
45. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
46. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build
47. Tuberculosis in patients undergoing maintenance hemodialysis
48. Risk of tuberculosis in dialysis patients: A population-based study
49. Tuberculosis in patients with end-stage renal disease
50. Tuberculosis and gastrectomy
51. Peptic ulcer, partial gastrectomy, and pulmonary tuberculosis
52. Jejunoileal bypass for obesisty. A risk factor for tuberculosis
53. Tuberculosis after jejunoileal bypass
54. Tuberculosis after jejunoileal bypass for obesity
55. Mycobacterial infection in renal transplant recipients: Report of five cases and review of the literature
56. Tuberculosis in heart transplant recipients
57. Mycobacterial in patients with malignant disease
58. Short-course chemoprophylaxis for tuberculosis
59. The action of antituberculosis drugs in short-course chemotherapy
60. Treatment of tuberculosis and other mycobacterial diseases
61. Treatment of tuberculosis and tuberculosis infection in adults and children
62. Treatment of tuberculosis and tubercolosis infection in adults and children
63. Prevention and control of tuberculosis in correctional facilities: Recommendations of the Advisory Council for the Elimination of Tuberculosis
64. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
65. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: An operational assessment at a voluntary counselling and testing centre
66. The challenge of tuberculosis statements on global control and prevention
67. Results of a directly-observed, intermittent isoniazid preventive therapy program in a shelter for homeless men
68. Normativa SEPAR sobre Diagnóstico de la Tuberculosis
69. Medidas básicas para el control de la tuberculosis en una comunidad
70. Principios de los programas de control de la tuberculosis en colaboracion con la UICTER
71. Proyecto de un programa nacional de control de la tuberculosis para España
72. Impact of chemoprophylaxis and BCG vaccination on the overall tuberculosis situation